Trending:

November 7, 2025, 04:25 PM - 2 min read
Mumbai-based drug-maker, Lupin, reported an increase in its consolidated profit after tax to ₹1,485 crore in the September quarter, led by growth in US and emerging markets
Read more
September 3, 2025, 03:29 PM - 2 min read
The approval by the US Food and Drug Administration (USFDA) is for the abbreviated new drug application (ANDA) for risperidone for extended-release injectable suspension, Indian pharma major Lupin said in a regulatory filing
Read more